Charles A. Rowland Jr - Jan 2, 2024 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Role
Director
Signature
/s/ Michael Morneau, as Attorney-in-Fact
Stock symbol
VKTX
Transactions as of
Jan 2, 2024
Transactions value $
$0
Form type
4
Date filed
1/4/2024, 09:27 PM
Previous filing
Dec 5, 2023
Next filing
Jan 24, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VKTX Stock Option (Right to Buy) Award $0 +32K $0.00 32K Jan 2, 2024 Common Stock 32K $18.28 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.